Mark S Leventhal, a director of ProPhase Labs, recently acquired 145,309 shares of the company. The buys took place at $1.61 per share, on August 18, 2015. Leventhal now owns 1,012,180 shares of the company. Leventhal operates out of Doylestown, PA. Some additional info was provided as follows:

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.59 to $1.61, inclusive. The reporting person and his wife control the Mark S & Donna R Leventhal Family Foundation Inc., a charitable foundation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

The above information was disc losed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!

Other recent filings from the company include the following:

BML Investment Partners, L.P. just provided an update on share ownership of ProPhase Labs - Jan. 30, 2018
ProPhase Labs's Chief Accounting Officer just declared owning 7,428 shares of ProPhase Labs - Jan. 23, 2018

Auto Refresh

Feedback